191 related articles for article (PubMed ID: 17426444)
1. AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines.
Koseoglu S; Lu Z; Kumar C; Kirschmeier P; Zou J
Cancer Biol Ther; 2007 May; 6(5):755-62. PubMed ID: 17426444
[TBL] [Abstract][Full Text] [Related]
2. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
3. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
[TBL] [Abstract][Full Text] [Related]
4. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.
Liu X; Shi Y; Birnbaum MJ; Ye K; De Jong R; Oltersdorf T; Giranda VL; Luo Y
J Biol Chem; 2006 Oct; 281(42):31380-8. PubMed ID: 16923802
[TBL] [Abstract][Full Text] [Related]
8. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
[TBL] [Abstract][Full Text] [Related]
9. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A; Krisanaprakornkit S
Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
[TBL] [Abstract][Full Text] [Related]
12. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
13. Akt isoform specific effects in ovarian cancer progression.
Linnerth-Petrik NM; Santry LA; Moorehead R; Jücker M; Wootton SK; Petrik J
Oncotarget; 2016 Nov; 7(46):74820-74833. PubMed ID: 27533079
[TBL] [Abstract][Full Text] [Related]
14. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
15. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
16. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
[TBL] [Abstract][Full Text] [Related]
18. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
19. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
[TBL] [Abstract][Full Text] [Related]
20. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.
Roy NK; Monisha J; Padmavathi G; Lalhruaitluanga H; Kumar NS; Singh AK; Bordoloi D; Baruah MN; Ahmed GN; Longkumar I; Arfuso F; Kumar AP; Kunnumakkara AB
Biomolecules; 2019 Jun; 9(7):. PubMed ID: 31252679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
